Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd.

No trades
See on Supercharts

Price target

11.590.00 0.00%
The 9 analysts offering 1 year price forecasts for SNPHF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to SNPHF in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

SNPHF EPS for the last quarter is 0.14 USD despite the estimation of 0.12 USD. In the next quarter EPS is expected to reach 0.12 USD. Track more of Santen Pharmaceutical Co., Ltd. financials and stay on top of what is up with the company.
In the next quarter Santen Pharmaceutical Co., Ltd. revenue is expected to reach ‪522.87 M‬ USD. Check out Santen Pharmaceutical Co., Ltd. revenue and earnings and make informed decisions.
According to analysts, SNPHF price target is 11.59 USD with a max estimate of 14.17 USD and a min estimate of 8.37 USD. Check if this forecast comes true in a year, meanwhile watch Santen Pharmaceutical Co., Ltd. stock price chart and keep track of the current situation with SNPHF news and stock market news.
We've gathered opinions of 9 analysts rating SNPHF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.